HemAware

This rebalancing agent can help people with hemophilia A or B — with or without inhibitors — to better control bleeding.

Advances include improved access to prophylaxis, multiple subcutaneous drugs in development, and research looking at better ways to personalize treatment.

Practical ways to stay grounded when constant news and uncertainty feel overwhelming.